Caitlin Kontulis
Direttore Finanziario/CFO presso PHIO PHARMACEUTICALS CORP.
Patrimonio netto: 7 769 $ in data 31/05/2024
Posizioni attive di Caitlin Kontulis
Società | Posizione | Inizio | Fine |
---|---|---|---|
PHIO PHARMACEUTICALS CORP. | Direttore Amministrativo | - | - |
Direttore Finanziario/CFO | - | - | |
Segretario Aziendale | - | - |
Storia della carriera di Caitlin Kontulis
Precedenti posizioni note di Caitlin Kontulis
Società | Posizione | Inizio | Fine |
---|---|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | 18/04/2011 | - |
Formazione di Caitlin Kontulis
Bryant University | Undergraduate Degree |
Northeastern University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Comptroller/Controller/Auditor | 1 |
Chief Administrative Officer | 1 |
Director of Finance/CFO | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
PHIO PHARMACEUTICALS CORP. | Health Technology |
Aziende private | 1 |
---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Borsa valori
- Insiders
- Caitlin Kontulis
- Esperienza